Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer

被引：0
|
作者：
Maria Karsten
Michelle Stempel
Julia Radosa
Sujata Patil
Tari A. King
机构：
[1] Memorial Sloan Kettering Cancer Center,Breast Service, Department of Surgery
[2] Memorial Sloan Kettering Cancer Center,Department of Epidemiology and Biostatistics
来源：
Annals of Surgical Oncology | 2016年 / 23卷
关键词：
Breast Cancer; Breast Cancer Mortality; Recurrence Score; Bilateral Breast Cancer; Progesterone Receptor Expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：471 / 476
页数：5
相关论文
共 50 条
  • [21] Incidental bilateral synchronous invasive breast cancer in a patient with low back pain
    Kundaktepe, Berrin Papila
    Durgun, Vedat
    Erginoz, Ergin
    Pekpak, Meltem
    Ilvan, Sennur
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14 : 197 - 199
  • [22] The Relationship of Race, Oncotype DX, and Ki67 in a Population Highly Screened For Breast Cancer
    Guth, Amber A.
    Kim, Jennifer Chun
    Schwartz, Shira
    Montes, Jennifer
    Snyder, Rebecca Akiko
    Axelrod, Deborah
    Schnabel, Freya
    BREAST JOURNAL, 2017, 23 (02): : 177 - 181
  • [23] Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy
    Enewold, Lindsey
    Geiger, Ann M.
    Zujewski, JoAnne
    Harlan, Linda C.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (01) : 149 - 156
  • [24] Genomic comparison of paired primary breast carcinomas and lymph node macrometastases using the Oncotype DX Breast Recurrence Score® test
    Susan K. Boolbol
    Manju Harshan
    Manjeet Chadha
    Laurie Kirstein
    Jean-Marc Cohen
    Paula Klein
    Joseph Anderson
    Deborah Davison
    Debbie M. Jakubowski
    Frederick L. Baehner
    Stephen Malamud
    Breast Cancer Research and Treatment, 2019, 177 : 611 - 618
  • [25] How Canadian Oncologists Use Oncotype DX for Treatment of Breast Cancer Patients
    Zhu, Xiaofu
    Dent, Susan
    Paquet, Lise
    Zhang, Tinghua
    Tesolin, Daniel
    Graham, Nadine
    Aseyev, Olexiy
    Song, Xinni
    CURRENT ONCOLOGY, 2021, 28 (01) : 800 - 812
  • [26] The effect of Oncotype DX® on adjuvant chemotherapy treatment decisions in early breast cancer
    Rabie, M. A.
    Rankin, A.
    Burger, A.
    Youssef, M. M. G.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2019, 101 (08) : 596 - 601
  • [27] Prognostic significance of synchronous and metachronous bilateral breast cancer
    James Kollias
    Ian O. Ellis
    Christopher W. Elston
    Roger W. Blamey
    World Journal of Surgery, 2001, 25 : 1117 - 1124
  • [28] Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy
    Lindsey Enewold
    Ann M. Geiger
    JoAnne Zujewski
    Linda C. Harlan
    Breast Cancer Research and Treatment, 2015, 151 : 149 - 156
  • [29] Synchronous bilateral breast cancer in a male
    Garcia-Mejido, Jose Antonio
    Delgado-Jimenez, Carmen
    Gutierrez-Palomino, Laura
    Sanchez-Sevilla, Miguel
    Iglesias-Bravo, Eva
    Caballero-Fernandez, Virginia
    CIRUGIA Y CIRUJANOS, 2013, 81 (03): : 225 - 227
  • [30] Bilateral synchronous breast cancer in a male
    Kahla, PB
    Cassaro, S
    Vladimir, FG
    Wayne, MG
    Cammarata, A
    MOUNT SINAI JOURNAL OF MEDICINE, 2005, 72 (02): : 120 - 123
12345